EirGenix Inc. (TPE:6589)
Taiwan · Delayed Price · Currency is TWD 48.65
+1.25 (2.64%)
Aug 5, 2026, 1:30 PM CST
EirGenix Market Cap
EirGenix has a market cap or net worth of 14.74 billion as of August 5, 2026. Its market cap has decreased by -22.76% in one year.
Market Cap
14.74B
Enterprise Value
13.00B
Revenue
1.13B
Ranking
n/a
PE Ratio
n/a
Stock Price
48.65
ChartMarket Cap Chart
Since November 23, 2016, EirGenix's market cap has increased from 4.56B to 14.74B, an increase of 223.31%. That is a compound annual growth rate of 12.85%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 5, 2026 | 14.74B | -21.08% |
| Dec 31, 2025 | 18.67B | -15.33% |
| Dec 31, 2024 | 22.05B | -28.29% |
| Dec 29, 2023 | 30.75B | -17.85% |
| Dec 30, 2022 | 37.43B | 11.81% |
| Dec 30, 2021 | 33.48B | 245.12% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Nov 23, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Oneness Biotech | 21.79B |
| Sunmax Biotechnology | 20.86B |
| TaiMed Biologics | 15.74B |
| Medigen Vaccine Biologics | 15.58B |
| Ever Supreme Bio Technology | 15.11B |
| Lumosa Therapeutics | 14.69B |
| ACRO Biomedical | 13.32B |
| Tanvex BioPharma | 10.07B |